Oncology & Cancer
Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
May 26, 2020
0
5
National Cancer Institute
Health
Higher daily step count linked with lower all-cause mortality
In a new study, higher daily step counts were associated with lower mortality risk from all causes. The research team, which included investigators from the National Cancer Institute (NCI) and the National Institute on Aging ...
Mar 24, 2020
0
138
Oncology & Cancer
Study provides genetic insights into osteosarcoma in children
A study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, offers new insight into genetic alterations associated with osteosarcoma, the most common cancerous bone tumor of children ...
Mar 19, 2020
0
88
Oncology & Cancer
In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1
Findings from a phase 2 clinical trial show that the drug selumetinib improves outcomes for children with the genetic disorder neurofibromatosis type 1 (NF1). In the trial, selumetinib shrank the inoperable tumors that develop ...
Mar 18, 2020
0
4
Cardiology
Automated CT biomarkers predict cardiovascular events better than current practice
Researchers at the National Institutes of Health and the University of Wisconsin have demonstrated that using artificial intelligence to analyze CT scans can produce more accurate risk assessment for major cardiovascular ...
Mar 5, 2020
0
1
Oncology & Cancer
Testing with combined biopsy method improves prostate cancer diagnosis
A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. This method, which combines ...
Mar 4, 2020
0
8
Oncology & Cancer
Immunotherapy drug improves outcomes for some children with relapsed leukemia
New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic ...
Dec 10, 2019
0
1
Oncology & Cancer
Study quantifies impact of NCI-sponsored trials on clinical cancer care
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network ...
Sep 18, 2019
0
0
Oncology & Cancer
Study finds increased risk of cancer death following treatment for hyperthyroidism
Findings from a study of patients who received radioactive iodine (RAI) treatment for hyperthyroidism show an association between the dose of treatment and long-term risk of death from solid cancers, including breast cancer. ...
Jul 1, 2019
0
0
Oncology & Cancer
Overall cancer mortality continues to decline
The latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decline in men, women, and children in the United States from 1999 to 2016. Overall ...
May 30, 2019
0
0
